Moxifloxacin (MOX) is a broad-spectrum fluoroquinolone antibiotic used in the treatment of various bacterial infections, including acute exacerbation of chronic bronchitis, community-acquired pneumonia, skin and soft tissue infections, complicated…
Using multiple discovery methods in aptamer development provides better binders. Learn why multiple discovery methods are important, which is right for you and how they can be combined for…
April 25th is DNA Day and we’re celebrating DNA aptamers and the innovation they are bringing from new medicines to new life science reagents. This day was set up…
Optimer® binders offer a solution for quick and convenient analysis of small molecule targets, such as drugs, vitamins, or hormones, through affinity-based assays. With a unique discovery process dedicated to small…
Small molecules are ubiquitous, from drugs such as chemotherapeutics and antibiotics, to food additives, such as vitamin supplements (folates), or environmental contaminants. Detecting and monitoring these molecules is vital…
Optimer beacons are reagents for simple, solution-based detection and analysis of target concentration. These beacons work by binding to specific analytes in a solution, resulting in a fluorescent…
Haptens are small molecules bound to a larger carrier protein to enable antibody discovery. This often yields antibodies with poor affinity and selectivity. Here we discuss why this is…
Drugs of abuse tests require highly selective, robust assays. Aptamers are helping to deliver new assays for more sensitive and simpler tests. According to the UN Office on Drugs…
Speed your small molecule detection and analysis with Optimer. Rapid development, rapid assays, rapid results. Download this datapack to learn how: success in discovery for small molecule ligand is increased…
Small molecules, like drugs, hormones, vitamins, and pesticides, are ubiquitous in our environment and form key analytes that are routinely monitored in healthcare and drug development. Our Optimer platform…
